ImpediMed Limited (ASX:IPD)
Australia · Delayed Price · Currency is AUD 0.0050
0.00 (0.00%)
Aug 28, 2026, 4:10 PM AEST
ImpediMed Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 14.61 | 14.61 | 12.72 | 10.32 | 11.34 | 10.57 |
Revenue Growth | 2.68% | 14.85% | 23.31% | -9.04% | 7.36% | 25.65% |
Gross Profit Gross Profit Growth | 12.77 | 12.77 | 10.98 | 9.01 | 9.8 | 8.86 |
Operating Income Operating Income Growth | -21.24 | -21.24 | -23.01 | -23.07 | -22.87 | -21.47 |
Net Income Net Income Growth | -24.91 | -24.91 | -23.24 | -19.79 | -20.52 | -19.87 |
Earnings Per Share EPS Growth | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
North America North America Growth | 11.48 | 9.28 | 8.26 | 6.1 |
Australia/Rest of World (ROW) Australia/Rest of World (ROW) Growth | 1.16 | 0.89 | 1.05 | 1.13 |
Unallocated Unallocated Growth | 0.09 | 0.15 | 2.04 | 3.34 |
Total Total Growth | 12.72 | 10.32 | 11.34 | 10.57 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 15.29 | 15.29 | 22.18 | 24.63 | 45.71 | 40.73 |
Total Debt Total Debt Growth | 16.6 | 16.6 | 14.49 | 1.14 | 1.45 | 0.17 |
Net Cash (Debt) Net Cash Growth | -1.31 | -1.31 | 7.69 | 23.49 | 44.26 | 40.56 |
Net Cash Growth | - | - | -67.25% | -46.93% | 9.13% | 111.17% |
Net Cash Per Share Net Cash Per Share Growth | -0.00 | -0.00 | 0.00 | 0.01 | 0.02 | 0.02 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -17.86 | -17.86 | -14.65 | -17.79 | -18.05 | -15.66 |
Capital Expenditures CapEx Growth | -0.07 | -0.07 | -0.06 | -0.08 | -0.39 | -0.06 |
Free Cash Flow Free Cash Flow Growth | -17.92 | -17.92 | -14.71 | -17.87 | -18.44 | -15.72 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 87.39% | 87.39% | 86.25% | 87.27% | 86.37% | 83.83% |
Operating Margin | -145.36% | -145.36% | -180.82% | -223.57% | -201.56% | -203.16% |
Pretax Margin | -170.27% | -170.27% | -182.42% | -191.46% | -180.62% | -187.66% |
Profit Margin | -170.44% | -170.44% | -182.62% | -191.78% | -180.90% | -188.09% |
FCF Margin | -122.64% | -122.64% | -115.57% | -173.18% | -162.56% | -148.82% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 28, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PS Ratio | 1.25 | 1.25 | 5.58 | 14.12 | 34.46 | 10.27 |